The prognostic value of plasma galectin-3 in chronic heart failure patients treated with mineralocorticoid receptor antagonists

被引：0
|
作者：
Rouet, P. [1 ]
Koukoui, F. [1 ]
Desmoulin, F. [1 ]
Barutaut, M. [1 ]
Caubere, C. [1 ]
Berry, M. [2 ]
Evaristi, M. [1 ]
Smih, F. [1 ]
Galinier, M. [2 ]
机构：
[1] UPS, INSERM, I2MC, U1048, Toulouse, France
[2] Univ Hosp Toulouse, Rangueil Hosp, INSERM, UPS,U1048, Toulouse, France
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P3674
引用
收藏
页码：673 / 673
页数：1
相关论文
共 50 条
  • [31] Prognostic uility of galectin-3 in Vietnamese patients with acute heart failure
    Toan, Dang
    Huong, Ta
    Hoang, S. Y.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 27 - 27
  • [32] The prognostic role of galectin-3 and endothelial function in patients with heart failure
    Tsigkou, Vasiliki
    Siasos, Gerasimos
    Oikonomou, Evangelos
    Zaromitidou, Marina
    Mourouzis, Konstantinos
    Dimitropoulos, Stathis
    Bletsa, Evanthia
    Gouliopoulos, Nikolaos
    Stampouloglou, Panagiota K.
    Panoilia, Maria-Evi
    Marinos, Georgios
    Tsioufis, Konstantinos
    Vavuranakis, Manolis
    Tousoulis, Dimitris
    CARDIOLOGY JOURNAL, 2023, 30 (05) : 725 - 733
  • [33] Diagnostic value of galectin-3 level in patients with chronic heart failure and type 2 diabetes
    Snetkova, A. A.
    Timofeeva, N. Yu.
    Zadionchenko, V. S.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2015, 11 (02) : 139 - 143
  • [34] Comparison the Prognostic Value of Galectin-3 and Serum Markers of Cardiac Extracellular Matrix Turnover in Patients with Chronic Systolic Heart Failure
    Chang, Yi-Yao
    Chen, Aaron
    Wu, Xue-Ming
    Hsu, Tse-Pin
    Liu, Li-Yu Daisy
    Chen, Yenh-Hsein
    Wu, Yen-Wen
    Lin, Hung-Ju
    Hsu, Ron-Bin
    Lee, Chi-Ming
    Wang, Shoei-Shen
    Lo, Men-Tzung
    Chen, Ming-Fong
    Lin, Yen-Hung
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2014, 11 (11): : 1098 - 1106
  • [35] Incremental value of mineralocorticoid receptor antagonists in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
    Benini, Annachiara
    Bingel, Anne
    Neumann, Konrad
    Edelmann, Frank
    Schoenrath, Felix
    Pieske, Burkert
    Messroghli, Daniel
    OPEN HEART, 2022, 9 (02):
  • [36] The association of galectin-3 and clinical parameters in patients with chronic heart failure
    Gyamdjyan, K. Karine
    Maximov, M. L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 490 - 491
  • [37] Galectin-3 as a Marker of Cardiorenal Syndrome in Patients with Chronic Heart Failure
    Podzolkov, V. I.
    Dragomiretskaya, N. A.
    Beliaev, I. G.
    Kazadaeva, A. V.
    Tolmacheva, A. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2022, 18 (02) : 153 - 159
  • [38] Galectin-3, oxidative stress and endotoxemia in patients with chronic heart failure
    Medvedeva, E. A. Elena
    Shchukin, Y. V.
    Surkova, E. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 214 - 214
  • [39] RELATIONSHIP OF GALECTIN-3 WITH HEMODYNAMIC PARAMETERS OF PATIENTS WITH CHRONIC HEART FAILURE
    Nurillaeva, N. M.
    Qurbonov, A. K.
    Nasretdenova, D. O.
    ATHEROSCLEROSIS, 2021, 331 : E235 - E235
  • [40] Plasma Concentrations of Galectin-3 in Patients with Suspected and Confirmed Heart Failure: Distribution, Associations and Prognostic Significance
    Sherwi, Nasser S.
    Goode, Kevin M.
    Zhang, Jufen
    Nicholls, Rachel
    Yassin, Ashraf
    Wong, Kennth
    Clark, Andrew
    Cleland, John
    CIRCULATION, 2011, 124 (21)
12345